ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

FY99 Appropriations: Congress Tells NCI To Fund More Research In Prostate Cancer

October 30, 1998

Breast Cancer Patients Track Symptoms With Digital Device

September 25, 2009

In Brief: While House Floats Healy’s Name For NIH Post; USC To Enhance Norris Center With NCI Grants

September 14, 1990

Some NCAB Members Lack Understanding f Bypass Budget’s Value, Purpose

September 1, 1989

Community Cancer Center Group Formed to Deal With “Toad-Like Pace Of NCI,” Other Problems

June 7, 1974

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995